Shoshi Arber, Xia Yuchen, Fieschi Andrea, Baumgarten Yannick, Gaißler Andrea, Ackermann Thomas, Reimann Peter, Mitschang Bernhard, Weyrich Michael, Bauernhansl Thomas, Miehe Robert
Graduate School of Excellence advanced Manufacturing Engineering (GSaME) University of Stuttgart Stuttgart Germany.
Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) Stuttgart Germany.
Healthc Technol Lett. 2025 May 13;12(1):e70012. doi: 10.1049/htl2.70012. eCollection 2025 Jan-Dec.
The chimeric antigen receptor T cell (CAR T) therapy has shown remarkable results in treating certain cancers. It involves genetically modifying a patient's T cells to recognize and attack cancer cells. Despite its potential, CAR T cell therapy is complex and costly and requires the integration of multiple technologies and specialized equipment. Further research is needed to achieve the maximum potential of CAR T cell therapies and to develop effective and efficient methods for their production. This paper presents an overview of current measurement methods used in the key steps of the production of CAR T cells. The study aims to assess the state of the art in monitoring solutions and identify their potential for online monitoring. The results of this paper contribute to the understanding of measurement methods in CAR T cell manufacturing and identify areas where on-line monitoring can be improved. Thus, this research facilitates progress toward the development of effective monitoring of CAR T cell therapies.
嵌合抗原受体T细胞（CAR T）疗法在治疗某些癌症方面已显示出显著效果。它涉及对患者的T细胞进行基因改造，使其能够识别并攻击癌细胞。尽管CAR T细胞疗法具有潜力，但它复杂且成本高昂，需要整合多种技术和专业设备。为了充分发挥CAR T细胞疗法的最大潜力并开发有效且高效的生产方法，还需要进一步研究。本文概述了CAR T细胞生产关键步骤中使用的当前测量方法。该研究旨在评估监测解决方案的技术现状，并确定其在线监测的潜力。本文的结果有助于理解CAR T细胞制造中的测量方法，并确定可改进在线监测的领域。因此，这项研究促进了朝着有效监测CAR T细胞疗法发展的进程。
